Work

Supplementary Materials from Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Materials from Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms

DOI: 10.1158/1940-6207.22523872.v1

Authors: Steven Lipkin, John Lee, David Imagawa, Stephen M. Hewitt, Chris Tucker, Jason A. Zell, Vanessa Wong, Angela Garcia, Rachel Gonzalez, Gary Della Zanna, Ellen Richmond, L.M. Rodriguez, M Bigg, F Schnoll-Sussmans, Frank Meyskens

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362537102

Cites:

Cited by:

Related to: 10